يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"İlhan Hacıbekiroğlu"', وقت الاستعلام: 1.37s تنقيح النتائج
  1. 1

    المساهمون: Acibadem University Dspace, BAŞOĞLU TÜYLÜ T., Sakin A., Erol C., Ozden E., ÇABUK D., Cilbir E., Tataroglu ozyukseler D., Ayhan M., Sendur M. A., Dogan M., et al.

    المصدر: Journal of Chemotherapy. 35:142-149

    مصطلحات موضوعية: Internal Diseases, PATOLOJİ, Pharmacy, Docetaxel, Sağlık Bilimleri, Fundamental Medical Sciences, Biochemistry, BIOLOGY & BIOCHEMISTRY, İç Hastalıkları, Clinical Medicine (MED), IMMUNOLOGY, Biyokimya, Surgery Medicine Sciences, Pathology, Biyoloji ve Biyokimya, FARMAKOLOJİ VE ECZACILIK, Klinik Tıp (MED), Pharmacology (medical), Patoloji, General Pharmacology, Toxicology and Pharmaceutics, Phase-Ii, Multicenter, PHARMACOLOGY & PHARMACY, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), PHARMACOLOGY & TOXICOLOGY, Klinik Tıp, Temel Bilimler, Basic Pharmaceutics Sciences, Life Sciences, Biyokimya (tıbbi), Genel Farmakoloji, Toksikoloji ve Eczacılık, Onkoloji, Regression, Tıp, Farmakoloji (tıbbi), Bulaşıcı hastalıklar, Oxaliplatin, Infectious Diseases, İlaç Rehberleri, Oncology, BULAŞICI HASTALIKLAR, Cerrahi Tıp Bilimleri, Farmakoloji ve Toksikoloji, Medicine, ONKOLOJİ, Folinic Acid, Fluorouracil, Natural Sciences, Histoloji, neoadjuvant chemotherapy, Histology, Farmakoloji, Temel Tıp Bilimleri, Life Sciences (LIFE), Genel İmmünoloji ve Mikrobiyoloji, Pathology and Forensic Medicine, Drug Guides, Yaşam Bilimleri, Health Sciences, Perioperative Chemotherapy, Farmakoloji, Toksikoloji ve Eczacılık (çeşitli), Eczacılık, Pharmacology, Internal Medicine Sciences, İmmünoloji, General Immunology and Microbiology, gastroesophageal junction cancer, Biochemistry (medical), Dahili Tıp Bilimleri, CLINICAL MEDICINE, Pharmacology and Therapeutics, Temel Eczacılık Bilimleri, Yaşam Bilimleri (LIFE), Surgery, Cisplatin, Gastric cancer, Patoloji ve Adli Tıp

    وصف الملف: application/pdf

  2. 2

    المساهمون: MÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Alkan, Ali, Karacin C., Oksuzoglu B., Demirci A., KESKİNKILIÇ M., Baytemür N. K., Yılmaz F., Selvi O., Erdem D., Avşar E., Paksoy N., et al., Demir, Hacer

    مصطلحات موضوعية: Internal Diseases, Cancer Research, GENETİK VE KALITIM, Receptor, ErbB-2, Endocrine treatment, retrospective study, Sağlık Bilimleri, İç Hastalıkları, Clinical Medicine (MED), survival analysis, BİYOKİMYA VE MOLEKÜLER BİYOLOJİ, Ribociclib, Antineoplastic Combined Chemotherapy Protocols, Klinik Tıp (MED), GENETICS & HEREDITY, Fulvestrant, antineoplastic agent, progression free survival, hormonal therapy, physician, Klinik Tıp, protein kinase inhibitor, breast tumor, adult, Temel Bilimler, Life Sciences, Onkoloji, Tıp, MOLECULAR BIOLOGY & GENETICS, aged, female, Oncology, monotherapy, Disease Progression, cancer therapy, Medicine, ONKOLOJİ, Advanced breast cancer, Natural Sciences, Medical Genetics, BIOCHEMISTRY & MOLECULAR BIOLOGY, Sitogenetik, cyclin dependent kinase inhibitor, Life Sciences (LIFE), Breast Neoplasms, Molecular Biology and Genetics, Palbociclib, Hormonotherapy, Article, cancer chemotherapy, cancer growth, Tıbbi Genetik, cancer combination chemotherapy, Yaşam Bilimleri, Health Sciences, Genetics, Humans, cyclin dependent kinase 6, controlled study, human, Cytogenetic, Everolimus, Genetik, Protein Kinase Inhibitors, Moleküler Biyoloji ve Genetik, cyclin dependent kinase 4, mammalian target of rapamycin, drug use, treatment duration, Internal Medicine Sciences, patient care, Cyclin-dependent kinase, Dahili Tıp Bilimleri, CLINICAL MEDICINE, major clinical study, drug efficacy, Yaşam Bilimleri (LIFE), disease exacerbation, epidermal growth factor receptor 2, Kanser Araştırmaları

    وصف الملف: application/pdf